Pyridostigmine

Pyridostigmine is a drug that has received approval by the U.S. Food and Drug Administration (FDA) under the brand name Mestinon to treat a condition called myasthenia gravis and under the brand name Regonol to reverse the effects of muscle relaxants. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include N, N-dimethyl(1-methyl(3-pyridyloxy))carboxamide and Pyridostigmine Bromine. Its PubChem CID is 4991.

CAS No 155-97-5
Molecular Formula C9H13N2O2+
Molecular Weight 181.21 g/mol
Synonyms (1-methylpyridin-1-ium-3-yl) N,N-dimethylcarbamate

Frequently Asked Questions